ABSTRACT
Primary angiitis of the central nervous system (PACNS) usually presents with symptoms of headache, cognitive impairment, or stroke with a mean age of onset at 50 years. Inflammation of the cerebral vessels can cause narrowing, occlusion, or thrombosis resulting in tissue ischemia and necrosis of the involved vessel territory. Findings can be seen on Magnetic Resonance Imaging (MRI) scans of the brain and serological markers of inflammation are typically within normal limits. The nonspecificity of PACNS presents a challenge for accurate diagnosis and must be differentiated from secondary vasculitis and Reversible Cerebral Vasoconstriction Syndrome (RCVS). Cerebral angiography, even though having low sensitivity and specificity, could sometimes be the only diagnostic tool available.
ABSTRACT
Creutzfeldt-Jakob disease (CJD) is a very rare neurodegenerative disorder that usually presents as rapidly progressive dementia with an extremely poor prognosis. The diagnosis of CJD can be extremely challenging due to its rarity, manifestation with non-specific neurological symptoms, associated broad differentials, and a need for extensive workup. Awareness of disease-specific biomarkers, radiological signs, and diagnostic criteria are crucial for timely diagnosis. Here, we report a case of CJD, which presented as an atypical movement disorder that progressed to dementia and failure to thrive within a few weeks of presentation.
ABSTRACT
BACKGROUND We present a case of invasive sinusitis with rhinocerebral infection in a patient who had mild symptoms of COVID-19 infection and did not receive any immunosuppressive therapies. CASE REPORT A 49-year-old man with a history of uncontrolled diabetes presented to the hospital with multiple generalized tonic clonic seizures. He had recently been diagnosed with mild COVID-19 and was treated at home with supportive care only. He was found to have cerebritis in the right frontal lobe along with right fronto-ethmoid sinusitis. He underwent extensive testing with nasal endoscopy with gram stain and culture, cryptococcal studies, 1-3-Beta-D glucan, blood cultures, fungal CSF studies, Lyme disease, HIV, Fungitell assay, and galactomannan studies, which were all negative. He was started on i.v. antibacterial therapy with cefepime, vancomycin, and metronidazole along with amphotericin B. After 2 weeks, his repeat imaging revealed progression of cerebritis along with new early abscess. Given these findings, his antibiotics were changed to meropenem and the amphotericin B dose was increased. He was recommended debridement and sinus surgery but refused. During the course of treatment, he developed acute kidney injury and was switched to Posaconazole. Unfortunately, the patient decided to leave against medical advice 6 weeks into admission. He was advised to continue Posaconazole and levofloxacin but he could only afford levofloxacin. He was then recommended long-term levofloxacin. He has since recovered, with resolution of cerebritis noted in follow-up imaging 1 year later. CONCLUSIONS Our patient had mild COVID-19 infection and presented with secondary infective complications, which are usually associated with an immunocompromised state, despite receiving no immunosuppressives. It is imperative that all clinicians treating COVID-19 be watchful for fungal or bacterial co-infections in patients with active SARS-CoV-2 infection, even if the presenting symptoms are mild, particularly if other risk factors are present.
Subject(s)
Brain Abscess , COVID-19 , Sinusitis , Brain Abscess/drug therapy , Humans , Immunocompromised Host , Male , Middle Aged , SARS-CoV-2ABSTRACT
A 36-year-old male presented with progressive exertional dyspnea over months. Physical examination showed jugular venous distension, lung crecipitations, femoral bruit and pitting pedal edema. Echocardiogram showed a dilated right ventricle with severe pulmonary hypertension and a non collapsing inferior vena cava (IVC). On right heart catheterization, IVC oxygen saturation was noted at 92% suggesting arterial mixing; a computed tomography of the abdomen showed a fistula between the right common iliac artery to the right common iliac vein at L4 level and a massive IVC; this was linked to trauma from a disectomy done 16 years ago at L4-L5 level. Endovascular sealing with a 16 × 60 mm bifurcated stent graft (S & G Biotech, Seoul, Korea) was performed which led to complete resolution of the patient's dyspnea. Iatrogenic vascular injury during lumbar disc surgery, although rare, can lead to high output cardiac failure developing over months to years.
Subject(s)
Arteriovenous Fistula/complications , Heart Failure/diagnosis , Intervertebral Disc Displacement/complications , Abdomen/diagnostic imaging , Adult , Arteriovenous Fistula/diagnostic imaging , Echocardiography , Endovascular Procedures , Heart Failure/etiology , Humans , Hypertension, Pulmonary/diagnostic imaging , Iliac Artery , Iliac Vein , Intervertebral Disc Displacement/surgery , Lumbar Vertebrae/surgery , Male , Stents , Tomography, X-Ray Computed , Vena Cava, InferiorSubject(s)
Gastroparesis/diagnostic imaging , Parkinson Disease/complications , Aged , Gastroparesis/etiology , Humans , Male , RadiographySubject(s)
Carotid Arteries/diagnostic imaging , Subclavian Artery/diagnostic imaging , Subclavian Steal Syndrome/diagnosis , Vertebral Artery/diagnostic imaging , Aged , Angiography , Arm , Echocardiography , Female , Humans , Hypesthesia/etiology , Subclavian Steal Syndrome/complications , Ultrasonography, DopplerSubject(s)
Cardiomyopathy, Hypertrophic/diagnostic imaging , Pulmonary Artery/diagnostic imaging , Pulmonary Embolism/diagnostic imaging , Adult , Angiography , Cardiomyopathy, Hypertrophic/diagnosis , Diagnosis, Differential , Humans , Male , Pulmonary Embolism/diagnosis , Tomography, X-Ray ComputedSubject(s)
Aortic Aneurysm, Abdominal/diagnostic imaging , Aortic Dissection/diagnostic imaging , Chest Pain/etiology , Echocardiography/methods , Pericardial Effusion , Point-of-Care Systems , Shock/etiology , Aged , Aortic Dissection/complications , Aortic Dissection/physiopathology , Aortic Aneurysm, Abdominal/complications , Aortic Aneurysm, Abdominal/physiopathology , Aortography/methods , Diagnosis, Differential , Emergency Medical Services/methods , Fatal Outcome , Humans , Male , Pericardial Effusion/diagnosis , Pericardial Effusion/etiology , Pericardial Effusion/physiopathology , Tomography, X-Ray Computed/methods , Vascular Surgical Procedures/methodsSubject(s)
Kidney Transplantation , Pneumatosis Cystoides Intestinalis/diagnosis , Pneumatosis Cystoides Intestinalis/therapy , Pneumoperitoneum/diagnosis , Pneumoperitoneum/therapy , Postoperative Complications/diagnosis , Postoperative Complications/therapy , Aged , Diagnosis, Differential , Humans , Male , Risk FactorsSubject(s)
Acute Coronary Syndrome , Coronary Artery Disease/diagnosis , Electrocardiography/methods , Female , Humans , MaleSubject(s)
Antiparkinson Agents/adverse effects , Fever/chemically induced , Indoles/adverse effects , Parkinson Disease/complications , Substance Withdrawal Syndrome/diagnosis , Substance Withdrawal Syndrome/etiology , Aged , Humans , Male , Parkinson Disease/drug therapy , Substance Withdrawal Syndrome/therapy , SyndromeABSTRACT
Ethylene glycol poisoning is a medical emergency that presents challenges for clinicians and clinical laboratories. If left untreated, it may cause morbidity and death, but effective therapy is available if diagnosed in time. The diagnosis of ethylene glycol poisoning is not always straightforward and the commonly quoted 'plasma osmolar gap' is not sufficiently sensitive to exclude a small ingestion and has been reported to be normal in a number of serious exposures. The 'plasma osmolar gap' cannot distinguish among ethanol, isopropyl alcohol, methanol or ethylene glycol. Thus, the measurement of serum ethylene glycol and, ideally, glycolic acid, its major toxic metabolite in serum, is definitive. This also holds true for methanol and its metabolite formic acid. Ethylene glycol metabolites target the kidney and lead to reversible oliguric or anuric injury, which in turn slows the elimination of ethylene glycol. The therapeutic options include reversal of metabolic acidosis, inhibition of alcohol dehydrogenase and early haemodialysis.